Kenneth A. Clark - Insider Trading & Ownership

Entity
Individual
Location
C/O Pharmacyclics, Inc., 995 East Arques Ave., Sunnyvale, CA
Summary
The estimated net worth of Kenneth A. Clark is at least $139K dollars as of January 4, 2024. Kenneth A. Clark is the Director of Summit Therapeutics Inc. and owns shares of Summit Therapeutics Inc. (SMMT) stock worth about $139K.
All Insider Reports
All Insider Reports

Ownership of Kenneth A. Clark

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
SMMT Summit Therapeutics Inc. Director $139K Jan 2, 2024
PLSE PULSE BIOSCIENCES, INC. Director May 20, 2021

Insider Transactions Reported by Kenneth A. Clark:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.